Daily Brief Australia: Nanosonics Ltd, Santos Ltd and more

• Nanosonics is poised for significant growth with the upcoming US launch of its new Coris® endoscope cleaning system in Q1 FY26, targeting a substantial new market segment beyond its established Trophon® franchise.
• The company operates a highly attractive ‘razor and blade’ business model, with a large installed base of its Trophon® ultrasound probe disinfection units driving recurring high-margin consumable sales.
• While the growth outlook is strong, the stock trades at premium valuation multiples, and faces key risks including competition, execution on the Coris® launch, and potential reliance on partners for new product success.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

• Following another unsuccessful bid for Santos, analysts review the company’s outlook with a focus on valuation and dividend support.
• -Santos’ takeover bid scuppered for the third time -Share price premium eases, focus returns to company fundamentals -Analysts review valuation and dividend support -Macquarie sees “extraordinary value” for long-term investors